CSIMarket Company Name, Ticker, Customers, else..
 
R1 Rcm Inc   (NASDAQ: RCM)
Other Ticker:  
 
 
Price: $14.3100 $0.01 0.070%
Day's High: $14.32 Week Perf: 0.14 %
Day's Low: $ 14.30 30 Day Perf: 0.42 %
Volume (M): 13,785 52 Wk High: $ 15.12
Volume (M$): $ 197,260 52 Wk Avg: $13.07
Open: $14.30 52 Wk Low: $10.10



 Market Capitalization (Millions $) 6,040
 Shares Outstanding (Millions) 422
 Employees 30,000
 Revenues (TTM) (Millions $) 2,464
 Net Income (TTM) (Millions $) -61
 Cash Flow (TTM) (Millions $) 2
 Capital Exp. (TTM) (Millions $) 105

R1 Rcm Inc
R1 RCM Inc. is a healthcare tech company that provides revenue cycle management (RCM) services to healthcare providers in the United States. Its headquarters is in Chicago, Illinois.

The company was founded in 2003 as Accretive Health Inc. by Mary Tolan, Michael Cline, and Brett Carlson. In 2011, it went public as Accretive Health, but it rebranded as R1 RCM in 201 Today, R1 RCM has over 21,000 employees working in over 300 hospitals and health systems in the US.

The company's primary service offering is revenue cycle management which covers everything from patient registration to billing and collections. The goal of this service is to optimize revenue cycles, increase claims processing efficiency, and reduce costs for healthcare providers. R1 RCM also offers value-based care solutions, medical coding services, and medical billing services to providers.

The company is a pioneer in the healthcare industry as it was one of the first to develop scalable, data-driven solutions that combine technology, human capital, and process optimizations to improve patient outcomes while lowering healthcare spending.

R1 RCM's technology solutions include proprietary revenue cycle management software, data analytics, and patient feedback tools. It leverages artificial intelligence to predict, identify, and solve revenue cycle management problems.

Overall, R1 RCM's mission is to create a sustainable future for the healthcare industry by offering innovative solutions and improving the quality of care delivered to patients. Through its performance-driven approach, the company aims to drive positive outcomes in both the patient experience and provider finances.


   Company Address: 433 W. Ascension Way Murray 84123 UT
   Company Phone Number: 324-7820   Stock Exchange / Ticker: NASDAQ RCM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DHX      % 
• View Complete Report
   



Merger and Acquisition

R1 RCM Enters New Era: TowerBrook and CD&R?s Acquisition Sparks Hope for Innovation in Healthcare Revenue Management,

Published Tue, Nov 19 2024 2:07 PM UTC

R1 RCM Transitions to Private Ownership: What This Means for Investors and the Future of Healthcare TechnologyIn a significant move for the healthcare technology industry, TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) have successfully completed their acquisition of R1 RCM, a leading provider of technology-enabled revenue cycle management services. With thi...
Merger and Acquisition

R1 RCM's $8.9 Billion Acquisition: Stockholders Cash In with $14.30 Per Share Payout

Published Thu, Aug 1 2024 11:31 AM UTC

Stockholders to Receive $14.30 Per Share in Cash Following R1 RCM Acquisition by TowerBrook and CD&R
In a significant development in the healthcare technology space, R1 RCM Inc. has announced plans to be acquired by TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) in a deal valued at an estimated $8.9 billion. This acquisition is not just transformative fo...
R1 Rcm Inc

R1 Rcm Inc Faces First Quarter Profitability Struggles Despite Strong Revenue Growth

R1 RCM Inc, a leading provider of technology-driven solutions in the healthcare industry, has seen a notable increase in revenue in the financial interval ending March 31, 2024. Despite this growth, the company also reported a loss per share, reflecting some challenges in their financial performance. The company's revenue gains have lagged behind their industry counterparts, with an average increase of 18.44% compared to the first quarter of 2023.
R1 RCM Inc is dedicated to assisting corporate clients in improving their operations and achieving financial success. The company is constantly seeking new opportunities to enhance its market position and drive growth. In light of this, R1 RCM Inc announced that its management team will be presenting at the 2024 Bank of America Securities Health Care Conference to showcase their innovative solutions and discuss their plans for the future.
Product Service News

R1 RCM Takes Proactive Steps: Forming Special Committee to Explore Strategic Alternatives and Unlock Growth Potential

Published Mon, Mar 11 2024 12:01 PM UTC

R1 RCM Forms Special Committee to Evaluate Strategic AlternativesMURRAY, Utah, March 11, 2024 - R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven healthcare solutions, has recently made a significant move to ensure its future growth and success. In response to the Schedule 13D/A filed by New Mountain Capital, L.L.C., the company has formed a special committe...
R1 Rcm Inc

R1 RCM Inc Reports $575.1 Million in Revenue for October to December 2023 Fiscal Period



R1 RCM Inc, a leading provider of technology-driven solutions in the healthcare industry, has recently reported its financial performance for the October to December 2023 fiscal period. Despite showing some positive results, the company's performance lags behind its peers in the Internet Services & Social Media sector. Furthermore, concerns have been raised by a significant shareholder about the undervaluation of the company by New Mountain Capital, LLC, signaling potential uncertainties in the company's future prospects.
Financial Performance Analysis:
During the October to December 2023 fiscal period, R1 RCM Inc reported a net loss per share of $0.00, which remained unchanged from the previous quarter but improved from a loss of $0.09 per share compared to the same quarter a year before. The company's revenue showed modest growth of 7.939% to $575.10 million in the current quarter, compared to $532.80 million in the same quarter a year ago. However, the sequential revenue increase of only 0.402% reflects a slower growth rate.






R1 Rcm Inc's Segments
Net fees    62.88 % of total Revenue
Incentive fees    3.41 % of total Revenue
Modular and other fee    33.71 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com